Alpha inflation in two stage design [Two-Stage / GS Designs]

posted by kumarnaidu – Mumbai, India, 2013-12-04 14:43 (4219 d 05:49 ago) – Posting: # 11999
Views: 25,531

Hi all,
In one of BEBAC presentation Page 45 http://bebac.at/lectures/Prague2012-2.pdf
a below statement is written.
Deficiency 2: The Applicant should demonstrate that the
type I error inflation which can be expected from the
chosen approach, did not impact on the decision of
bioequivalence.

Response 2: One million simulations based on study’s
sample size and CV.
αemp 0.0494 (95% CI: 0.0490 – 0.049)

Here I want to ask if I want to demonstrate that type error inflation did not impact on my study then can I demonstrate this by simply showing 90% CI as well as 94.12% CI for GMR of PK parameters within the acceptance limits (80% to 125%).
also I am not getting how to interpret Response 2

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
46 visitors (0 registered, 46 guests [including 11 identified bots]).
Forum time: 21:32 CEST (Europe/Vienna)

Reach for the stars,
even if you have to stand on a cactus.    Susan Longacre

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5